期刊文献+

缺失TA35R基因减毒天坛株痘苗病毒的构建及筛选

Construction and selection of the attenuated vaccinia Tiantan strain with deleted TA35R gene
原文传递
导出
摘要 通过敲除痘苗病毒天坛株(vaccinia virus tiantan strain,VTT)复制非必需基因TA35R,结合双筛选标记及同源重组技术,构建TA35R基因缺失的VTT弱毒株rVTT-TA35R-。人工合成含有TA35R重组臂、同向loxp序列、早晚期启动子PE/L、EGFP及酶切位点的穿梭质粒pTA35R-EGFP。pTA35R-EGFP和野生型VTT共转染BHK-21细胞,通过绿色荧光蚀斑筛选,构建缺失TA35R基因且含FGFP基因的重组痘苗病毒rVTT-TA35R--EGFP+。采用Cre/Loxp系统敲除外源筛选标记EGFP,获得缺失TA35R基因的重组痘苗病毒rVTT-TA35R-,利用PCR方法和电子显微镜对其进行鉴定,通过MTT法检测细胞噬性以评价其减毒效果。结果表明,所构建的痘苗病毒弱毒株rVTT-TA35R-完全缺失了TA35R基因和外源筛选标记EGFP,且细胞毒性减弱。 The attenuated vaccinia Tiantan strain(VTT)with deleted TA35 R gene(rVTTTA35R-)was constructed through the technology of homologous recombination,double marking screening and gene knockout.Shuttle vector plasmids named as pTA35R-EGFP was compound of synthetic recombinant arms of TA35 R,loxp sequence in the same direction,EGFP,sooner or later promoter PE/L and restriction enzyme cutting site.BHK-21 cells were co-transfected with pTA35R-EGFP and wild type VTT.The modified virus rVTT-TA35R--EGFP+in which TA35 Rgene was replaced with the EGFP gene was screened by fluorescent plaque purification.rVTT-TA35R-without exogenous screen signal was obtained by knocking out selection markers with Cre/Loxp system and identified by PCR and electron microscope,and attenuated capability evaluation by MTT assay.The results showed that the TA35 Rgene and the EGFP gene had been removed completely from rVTT-TA35R-,and the cell virulence was declined.
出处 《中国兽医学报》 CAS CSCD 北大核心 2014年第12期1883-1887,共5页 Chinese Journal of Veterinary Science
基金 国家863计划资助项目(2012AA02A407) 国家新药创制科技重大专项资助项目(2014Z×09304314-002) 国家自然科学基金资助项目(81101140) 吉林省产业技术创新战略联盟资助项目(20140309006YY) 吉林省重点科技攻关资助项目(2013206041NY)
关键词 天坛株痘苗病毒 TA35R基因 同源重组 病毒载体 vaccinia Tiantan TA35Rgene homologous recombination virus vector
  • 相关文献

参考文献6

  • 1Kristina E. Rehm,Rachel L. Roper.Deletion of the A35 gene from Modified Vaccinia Virus Ankara increases immunogenicity and isotype switching[J].Vaccine.2011(17)
  • 2Kaifan Dai,Ying Liu,Mingjie Liu,Jianqing Xu,Wei Huang,Xianggang Huang,Lianxing Liu,Yanmin Wan,Yanling Hao,Yiming Shao.Pathogenicity and immunogenicity of recombinant Tiantan Vaccinia Virus with deleted C12L and A53R genes[J].Vaccine.2008(39)
  • 3Patricia Nell,Katrin S. Kohl,Philip L. Graham,Philip S. LaRussa,S. Michael Marcy,Vincent A. Fulginiti,Bryan Martin,Ann McMahon,Scott A. Norton,Ingrid Trolin.Progressive vaccinia as an adverse event following exposure to vaccinia virus: Case definition and guidelines of data collection, analysis, and presentation of immunization safety data[J].Vaccine.2007(31)
  • 4王宇航,李霄,王浩然,阚式绂,王卓越,齐延新,吴娜,杜寿文,金宁一.缺失E3L基因减毒天坛株痘苗病毒的构建及筛选[J].中国兽医学报,2011,31(11):1619-1622. 被引量:4
  • 5盛媛,王浩然,胡宁宁,陈智飞,王宏宇,姜爽,周晔,李一权,李霄,金宁一.天坛株痘苗病毒基因缺失弱毒株的构建及鉴定[J].中国兽医学报,2014,34(3):384-389. 被引量:7
  • 6庞聪,田厚文.非复制型痘苗病毒的生物学性状研究进展[J].生物技术通讯,2014,25(3):415-420. 被引量:5

二级参考文献81

  • 1吴壮,徐军.Cre/Loxp位点重组酶系统在疾病动物模型建立中的应用[J].国外医学(呼吸系统分册),2004,24(4):254-256. 被引量:4
  • 2娄元梅,阮力,朱既明.痘苗病毒毒力相关基因的研究进展[J].病毒学报,1996,12(1):88-96. 被引量:2
  • 3Harari A,Bart P A,Stohr W,et al. An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and loog-lasting T cell respon- ses[J]. J Exp Med,2008,205:63-77.
  • 4Pastoret P P,Brochier B. The development and use of a vaccinia-rabies recombinant oral vaccine for the control of wildlife rabies; a link between Jenner and Pasteur[J].Epidemiol Infect,1996,116(3) :235-240.
  • 5Duncan S A,Smith G L. Identification and characteriza- tion of an extracellular envelope glyeoprotein affecting vaccinia virus egress[J]. J Virol, 1992,66 : 1610-1621.
  • 6Wollenberg A, Engler R. Smallpox, vaccination and ad- verse reactions to smallpox vaecine[J]. Curr Opin Al- lergy Clin Immunol, 2004,4 : 271-275.
  • 7Jentarra G M,Heck M C,Youn J W,et al. Vaccinia vi- ruses with mutations in the E3L gene as potential rep- lication-competent, attenuated vaccines: scarification vaccination[J]. Vaccine, 2008,26 (23) : 2860-2872.
  • 8Li X,Jin N Y,Mi Z Q,et al. Antitumor effects of a re- combinant fowlpox virus expressing Apoptin in vivo and in vitro [J]. Int J Cancer, 2006,119 : 2948-2957.
  • 9Ami Y, Izumi Y, Matsuo K, et al. Priming-boosting vaccination with recombinant Mycobacteriurn boris ba- cillus Calmette-Guerin and a nonreplicating vaccinia vi-rus recombinant leads to long-lasting and effective im- munity[J]. J Virol,2005,79(20) :12871 12879.
  • 10Gilbert S C,Moorthy V S,Andrews L,et al. Synergis- tic DNA-MVA prime-boost vaccinationregimes for malaria and tuberculosis[J]. Vaccine, 2005,5 - 5.

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部